Literature DB >> 7594333

Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.

Y Otani1, M Kitajima, M Sugiyama, Y Watanabe, T Aoki.   

Abstract

The inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion caused by stress after surgical invasion were studied in patients who underwent surgery under general anesthesia for gastrointestinal diseases. Patients in this study received either 15 mg or 30 mg of lansoprazole by slow intravenous injection twice daily for 3 days (six injections). The total number of patients studied was 82, with 41 patients in each group. Intragastric pH was measured every 8 h after the start of administration, and the inhibitory effects of intravenous lansoprazole on postoperative gastric acid secretion were evaluated using four grades: excellent, good, fair, and poor. In the 15-mg group, 65.8% (25 of 38 patients) were classified as good or excellent, and in the 30-mg group, 75.7% (28 of 37 patients) were good or excellent. No adverse effects directly attributable to the administration of lansoprazole were observed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594333     DOI: 10.1097/00004836-199506002-00007

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

Review 1.  Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.

Authors:  H D Langtry; M I Wilde
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

2.  Stress ulcer bleeding.

Authors:  Richard F Harty; Hari B Ancha
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

Review 3.  Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.

Authors:  P Richardson; C J Hawkey; W A Stack
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

Review 4.  Switching between intravenous and oral pantoprazole.

Authors:  J R Pisegna
Journal:  J Clin Gastroenterol       Date:  2001-01       Impact factor: 3.062

Review 5.  Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.

Authors:  Stephen Brett
Journal:  Crit Care       Date:  2004-10-08       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.